Dr.Melaxin TX Retinalsome Double Effect Eye Cream, 1.41 oz (40 g)
Product details
| Management number | 230417050 | Release Date | 2026/06/18 | List Price | US$13.44 | Model Number | 230417050 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Anti-Eye Wrinkle Diminish Dark Circle Tube Type Dermatologist Tested Dr. Melaxin TX Retinalsome Double Effect Eye Cream Tranexamic Acid - Niacinamide / Adenosine Retinalsome - Retinal 500 ppm / Tocoperol Tranexamic acid has a structure similar to melanin and acts as a competitive inhibitor to inhibit the activity of Tyrosinase. [Dose of Ingredients] out of 40 g : Main ingredient : 1: Tranexamic Acid - 3.5%. 2: Retinal - 500 ppm. Functional ingredient : 1,2: Niacinamide - 2%. 1,2: Adenosine - 0.04%. Patent Number : 10 - 1848887. Tranexamic acid-peptide composition. A dual-formula eye cream containing Tranexamic acid cream (Formula 1) and Retinal formulated with liposome technology (Formula 2).
- Anti-Eye Wrinkle
- Diminish Dark Circle
- Tube Type
- Dr
- Melaxin TX Retinalsome Double Effect Eye CreamTranexamic Acid - Niacinamide / AdenosineRetinalsome - Retinal 500 ppm / Tocoperol Tranexamic acid has a structure similar to melanin and acts as a competitive inhibitor to inhibit the activity of Tyrosinase
| Brand | Dr.Melaxin |
|---|---|
| Skin care concern | Aging |
| Rec. use | Day Use |
| Skin type | All |
| Form | Cream |
| Container type | Bottle |
| Size | 5.35 |
| Net content statement | 8809886481840 |
| Product net content uom | Gram |
| Product net content parent | 8809886481840 Gram |
| Occasion | All Season, Halloween, Black Friday, Cyber Monday |
| Body part | Eye |
| Multipack quantity | 1 |
| Age group | Adult |
| Label image | Ingredient List, OTC Dosage / Instructions |
| Ingredient list image | https://s3.images-iherb.com/dmx/dmx48184/l/59.jpg |
| Gender | Unisex |
Bestseller ranking
Eye Serums
Customers who viewed this product also viewed
Kids Vitamin C
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form